Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

34
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
34
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

38
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
38

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TRPV1 Activation Is Associated with Improved Mitochondrial Function and Cardioprotection in Experimental Hypertension.

Molecules (Basel, Switzerland)·2026
Same author

Sulforaphane protects cardiomyoblasts against chemical hypoxia by increasing mitochondrial-ER communication and autophagy.

Chemico-biological interactions·2026
Same author

High-grade left atrial intimal sarcoma mimicking myxoma: The diagnostic and therapeutic relevance of tumor topography.

Journal of cardiology cases·2026
Same author

Apical Right Ventricular Sequestration with Left Ventricular Hypertrabeculation: Multimodal Imaging Evaluation in an Adolescent.

JACC. Case reports·2026
Same author

Cardiovascular and Clinical Manifestations of Marfan Syndrome and Other Inherited Connective Tissue Disorders with Coexisting Genetic Variants.

Cells·2026
Same author

Reply to Nguyen et al. Over-Intake of Plant-Derived Antioxidants, H<sub>2</sub>S Generation, and Reductive Stress. Comment on "Manzano-Pech et al. The Chronic Elevated Consumption of <i>Hibiscus sabdariffa</i> Linnaeus Results in Kidney Damage Associated with Excess H<sub>2</sub>S. <i>Int. J. Mol. Sci.</i> 2026, <i>27</i>, 2190".

International journal of molecular sciences·2026

Related Experiment Video

Updated: Sep 2, 2025

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.5K

Bioprosthesis in aortic valve replacement: long-term inflammatory response and functionality.

Huitzilihuitl Saucedo-Orozco1,2, Jesus Vargas-Barron3, Ricardo Márquez-Velazco4

  • 1Cardioneumology, Instituto Nacional de Cardiologia Ignacio Chavez, Ciudad de Mexico, Mexico.

Open Heart
|August 4, 2022
PubMed
Summary

Postoperative aortic valve replacement (AVR) patients show persistent inflammation linked to prosthesis type and patient factors. Understanding these inflammatory markers can improve long-term outcomes and bio-prosthesis durability.

Keywords:
Aortic Valve InsufficiencyAortic Valve StenosisEchocardiographyHeart Valve Prosthesis

More Related Videos

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.2K
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.0K

Related Experiment Videos

Last Updated: Sep 2, 2025

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.5K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.2K
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.0K

Area of Science:

  • Cardiovascular Surgery
  • Immunology
  • Biomaterials Science

Background:

  • Long-term inflammatory response after aortic valve replacement (AVR) is critical for prosthesis durability and function.
  • Preventing reoperation and enhancing prosthetic longevity are key clinical goals.
  • Understanding postoperative inflammation is essential for improving patient outcomes.

Purpose of the Study:

  • To evaluate long-term inflammatory response and function in patients following AVR.
  • To identify factors associated with prosthetic valve dysfunction.
  • To explore potential strategies for prolonging bio-prosthesis functionality.

Main Methods:

  • A cohort study including patients undergoing AVR with mechanical or biological prostheses, and a control group.
  • Analysis of inflammatory markers (IL-4, osteopontin, OPG, ET-1, IL-6, IL-1ß, TNFα).
  • Comparison of marker levels based on prosthesis type, gender, age, and time since AVR.

Main Results:

  • Mechanical prostheses showed higher IL-4 and osteopontin levels compared to biological ones.
  • Osteoprotegerin (OPG) levels were decreased in patients with mechanical prostheses.
  • Elevated IL-1ß and ET-1 levels, along with age and gender, were associated with prosthetic valve dysfunction.

Conclusions:

  • Pre-existing inflammation may persist post-AVR, influenced by various long-term factors.
  • Specific inflammatory markers and patient demographics are linked to prosthetic valve dysfunction.
  • Findings may guide targeted treatments to enhance bio-prosthesis longevity.